Sensorion Announces Candidate Selection for GJB2 Gene Therapy Program streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
CTA filing for OTOF-GT planned for Q2 2023 Presented new preclinical data supporting continued progress of OTOF-GT, and potential for safe and efficient clinical translation of gene therapy
Thursday April 6, 2023, at 8am EDT, 2pm CEST Regulatory News: Sensorion, (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company, specialising in the development of novel therapies
Stock Market | Daily Herald dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.